Corrigendum: Circulating exosomal microRNA profiles in migraine patients receiving acupuncture treatment: a placebo-controlled clinical trial

Lu Liu^#¹, Wenchuan Qi^#^{1

2}, Yanan Wang¹, Xixiu Ni¹, Shan Gao¹, Ziyang Zhou¹, Daohong Chen¹, Zhenxi He¹, Mingsheng Sun¹, Ziwen Wang¹, Dingjun Cai^{1

2}, Ling Zhao^{1

2}

Affiliations

¹ Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
² Acupuncture and Chronobiology Key Laboratory of Sichuan Province, Chengdu, Sichuan, China.

^# Contributed equally.

Published Erratum

Lu Liu et al. Front Mol Neurosci. 2023.

. 2023 Apr 20:16:1174810.

doi: 10.3389/fnmol.2023.1174810. eCollection 2023.

Lu Liu^#¹, Wenchuan Qi^#^{1

2}, Yanan Wang¹, Xixiu Ni¹, Shan Gao¹, Ziyang Zhou¹, Daohong Chen¹, Zhenxi He¹, Mingsheng Sun¹, Ziwen Wang¹, Dingjun Cai^{1

2}, Ling Zhao^{1

2}

¹ Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
² Acupuncture and Chronobiology Key Laboratory of Sichuan Province, Chengdu, Sichuan, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fnmol.2022.1098766.].

Keywords: acupuncture; biomarker; exosome; miRNA; migraine.

Circulating exosomal microRNA profiles in migraine patients receiving acupuncture treatment: A placebo-controlled clinical trial.
Liu L, Qi W, Wang Y, Ni X, Gao S, Zhou Z, Chen D, He Z, Sun M, Wang Z, Cai D, Zhao L. Liu L, et al. Front Mol Neurosci. 2023 Jan 10;15:1098766. doi: 10.3389/fnmol.2022.1098766. eCollection 2022. Front Mol Neurosci. 2023. PMID: 36704329 Free PMC article.